📖

slc22a1

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-slc22a1

Related Entities

Metadata

slug	genes-slc22a1
entity_type	gene
kg_node_id	SLC22A1

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (257)

see_also📖LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE80%

see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and75%

see_also📖LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy for 75%

see_also📖nct0550878975%

see_also📖remternetug-anti-amyloid-alzheimers75%

see_also📖UPenn Observational Research Repository (NCT04715399)75%

see_also📖APOE4 (Apolipoprotein E4)75%

mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming70%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer70%

mentions🧪APOE Isoform Conversion Therapy70%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones70%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction70%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy70%

mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%

mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy70%

mentions🧪Competitive APOE4 Domain Stabilization Peptides70%

mentions🧪APOE Isoform Expression Across Glial Subtypes70%

see_also📖ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT0739270%

see_also📖APOE2 (Apolipoprotein E2)70%

see_also📖APOE3 (Apolipoprotein E3)70%

see_also📖Cell-Free DNA Biomarkers in Neurodegeneration65%

see_also📖Exosomal Biomarkers in Neurodegeneration65%

see_also📖Exosomal miR-155 in Neurodegeneration65%

see_also📖IL-6 (Interleukin-6) in Neurodegeneration65%

see_also📖Liquid Biopsy in Neurodegeneration65%

see_also📖Metabolomic Biomarkers in Neurodegeneration65%

see_also📖Neuroimaging Biomarkers for Neurodegeneration65%

see_also📖Synaptic Biomarkers in Neurodegeneration65%

see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl65%

see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 65%

see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)65%

see_also📖China Neurodegeneration Epidemiology65%

see_also📖DALY Methodology — Neurodegeneration65%

see_also📖Disease Progression & Staging in Neurodegeneration65%

see_also📖Economic Burden — Neurodegeneration65%

see_also📖European Neurodegeneration Epidemiology65%

see_also📖Familial vs Sporadic Neurodegeneration Comparison65%

see_also📖Global Neurodegeneration Epidemiology65%

see_also📖India Neurodegeneration Epidemiology65%

see_also📖Japan Neurodegeneration Epidemiology65%

see_also📖Manganese-Related Neurodegeneration (Manganism)65%

see_also📖mitochondrial-dysfunction-neurodegeneration-comparison65%

see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr65%

see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 65%

see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)65%

see_also📖Potential Impact Measures — Neurodegeneration65%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)65%

see_also📖PLA2G6-Associated Neurodegeneration (PLAN)65%

see_also📖Sleep Disorders in Neurodegeneration65%

see_also📖US Neurodegeneration Epidemiology65%

see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread65%

see_also📖acetylcholine-signaling-neurodegeneration65%

see_also📖Advanced Glycation End Products in Neurodegeneration65%

see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 65%

see_also📖Amylin Signaling in Neurodegeneration65%

see_also📖Antibody Therapy in Neurodegeneration65%

see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration65%

see_also📖Autosis Pathway in Neurodegeneration65%

see_also📖Axon Guidance Pathways in Neurodegeneration65%

see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration65%

see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain65%

see_also📖CaMKII Signaling Pathway in Neurodegeneration65%

see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration65%

see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration65%

see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration65%

see_also📖Cholinergic System Dysfunction in Neurodegeneration65%

see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat65%

see_also📖Neural Circuits in Neurodegeneration65%

see_also📖Cognitive Reserve and Resilience in Neurodegeneration65%

see_also📖Computational Disease Models for Neurodegeneration65%

see_also📖Convergent Pathways in Neurodegeneration65%

see_also📖Copper Homeostasis in Neurodegeneration65%

see_also📖COVID-19 Neurodegeneration Mechanism65%

see_also📖Diffusion MRI (DTI) in Neurodegeneration65%

see_also📖Digital Phenotyping in Neurodegeneration65%

see_also📖Down Syndrome Neurodegeneration Pathway65%

see_also📖Dystrophic Neurites in Neurodegeneration65%

see_also📖Endocannabinoid System in Neurodegeneration65%

see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration65%

see_also📖Endosomal Sorting Defects in Neurodegeneration65%

see_also📖Endothelin Signaling Pathway in Neurodegeneration65%

see_also📖epigenetics-neurodegeneration65%

see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration65%

see_also📖FA2H-Associated Neurodegeneration Pathway65%

see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration65%

see_also📖Galectin-3 Mechanism in Neurodegeneration65%

see_also📖Gangliosides in Neurodegeneration65%

see_also📖GDF15/GDF11 Signaling in Neurodegeneration65%

see_also📖GDNF Signaling Pathway in Neurodegeneration65%

see_also📖Ghrelin Signaling Pathway in Neurodegeneration65%

see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration65%

see_also📖Glycosylation in Neurodegeneration65%

see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration65%

see_also📖Hippocampal Neurogenesis in Neurodegeneration65%

see_also📖Histone Modification Pathways in Neurodegeneration65%

see_also📖HMGB1 Signaling in Neurodegeneration65%

see_also📖Homocysteine Neurotoxicity and Neurodegeneration65%

see_also📖IGF-1 Signaling Pathway in Neurodegeneration65%

see_also📖IL-1 Signaling Pathway in Neurodegeneration65%

see_also📖Integrated Stress Response in Neurodegeneration65%

see_also📖interleukin-6-signaling-neurodegeneration65%

see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration65%

see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 65%

see_also📖Kidney-Brain Neurodegeneration Axis65%

see_also📖Lipid Dysregulation in Neurodegeneration65%

see_also📖Lipid Metabolism Dysregulation in Neurodegeneration65%

see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration65%

see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration65%

see_also📖Metal Homeostasis Dysregulation in Neurodegeneration65%

see_also📖Metal Homeostasis in Neurodegeneration65%

see_also📖Microglial Priming Pathway in Neurodegeneration65%

see_also📖MicroRNA Dysfunction in Neurodegeneration65%

see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration65%

see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration65%

see_also📖Mitochondrial Fusion in Neurodegeneration65%

see_also📖Molecular Chaperones in Neurodegeneration65%

see_also📖mTOR Signaling in Neurodegeneration65%

see_also📖mTOR Signaling Pathway in Neurodegeneration65%

see_also📖Neural Circuit Disruption in Neurodegeneration65%

see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N65%

see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati65%

see_also📖Neuronal Hyperexcitability in Neurodegeneration65%

see_also📖Neuropil Threads in Neurodegeneration65%

see_also📖Neurotensin Signaling in Neurodegeneration65%

see_also📖Neurovascular Unit Dysfunction in Neurodegeneration65%

see_also📖NF-kB Signaling Pathway in Neurodegeneration65%

see_also📖Nitric Oxide Signaling in Neurodegeneration65%

see_also📖Noradrenergic Signaling Pathway in Neurodegeneration65%

see_also📖Neuropeptide Y Signaling in Neurodegeneration65%

see_also📖NRF2 Signaling Pathway in Neurodegeneration65%

see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration65%

see_also📖Orexin Signaling in Neurodegeneration65%

see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration65%

see_also📖P-Body (Processing Body) Pathway in Neurodegeneration65%

see_also📖Paranodal Dysfunction in Neurodegeneration65%

see_also📖Paraptosis in Neurodegeneration65%

see_also📖Parthanatos in Neurodegeneration65%

see_also📖Pericyte Loss in Neurodegeneration65%

see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration65%

see_also📖PKR Pathway in Neurodegeneration65%

see_also📖PPAR Signaling Pathway in Neurodegeneration65%

see_also📖Prion Diseases in Neurodegeneration65%

see_also📖Prion-Like Spread in Neurodegeneration65%

see_also📖Prion Protein Metabolism in Neurodegeneration65%

see_also📖Progesterone Signaling Pathway in Neurodegeneration65%

see_also📖Prognostic Biomarkers in Neurodegeneration65%

see_also📖Protein Aggregation Comparison in Neurodegeneration65%

see_also📖Protein Aggregation Seeds in Neurodegeneration65%

see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration65%

see_also📖Cortical Involvement and Neurodegeneration in Progressive Su65%

see_also📖Purinergic Signaling in Neurodegeneration65%

see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener65%

see_also📖R-Loop Stress in Neurodegeneration65%

see_also📖RAN Translation in Neurodegeneration65%

see_also📖Retinal Degeneration Pathway in Neurodegeneration65%

see_also📖Ribosome Dysfunction in Neurodegeneration65%

see_also📖RNA Splicing in Neurodegeneration65%

see_also📖RNA-Targeted Therapies in Neurodegeneration65%

see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a65%

see_also📖S100 Protein Signaling Pathway in Neurodegeneration65%

see_also📖Senescent Cell Clearance in Neurodegeneration65%

see_also📖Serotonergic Dysfunction in Neurodegeneration65%

see_also📖Sex Differences in Neurodegeneration65%

see_also📖Short Chain Fatty Acids in Neurodegeneration65%

see_also📖Sigma-1 Receptor Signaling in Neurodegeneration65%

see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration65%

see_also📖Sleep Dysfunction in Neurodegeneration65%

see_also📖SUMOylation in Neurodegeneration65%

see_also📖synaptic-vesicle-cycling-neurodegeneration65%

see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration65%

see_also📖T-Cell Dysfunction in Neurodegeneration65%

see_also📖Tertiary Lymphoid Organs in Neurodegeneration65%

see_also📖Therapeutic Targets in Neurodegeneration65%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration65%

see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration65%

see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration65%

see_also📖Vagus Nerve Pathway in Neurodegeneration65%

see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio65%

see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio65%

see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen65%

see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration65%

related🧪Synthetic Biology BBB Endothelial Cell Reprogramming63%

related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides63%

related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer60%

related🧪APOE Isoform Conversion Therapy60%

related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones60%

related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction60%

related🧪Targeted APOE4-to-APOE3 Base Editing Therapy60%

related🧪APOE4-Selective Lipid Nanoemulsion Therapy60%

related🧪Competitive APOE4 Domain Stabilization Peptides60%

related🧪APOE Isoform Expression Across Glial Subtypes60%

related🧪Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A60%

see_also📖Neurodegeneration60%

see_also📖PPAR (Peroxisome Proliferator-Activated Receptor)60%

see_also📖ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member 160%

see_also📖CHRNA7 Gene60%

see_also📖CYP2D6 — Cytochrome P450 2D660%

see_also📖CYP3A4 — Cytochrome P450 3A460%

see_also📖ACE Gene60%

see_also📖Genes60%

see_also📖BCHE Gene - Butyrylcholinesterase60%

see_also📖CHAT Gene60%

see_also📖hypotheses-apoe-contributes-alzheimers-disease-regulat60%

see_also📖Alzheimer Indonesia60%

see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh55%

see_also📖NCT07477431 - Levetiracetam for Persons at Risk for Alzheime55%

see_also📖TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di55%

related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer54%

related🧪APOE Isoform Conversion Therapy54%

related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones54%

related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction54%

related🧪Targeted APOE4-to-APOE3 Base Editing Therapy54%

related🧪APOE4-Selective Lipid Nanoemulsion Therapy54%

related🧪Competitive APOE4 Domain Stabilization Peptides54%

related🧪APOE Isoform Expression Across Glial Subtypes54%

related🧪Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A54%

related🔬What are the mechanisms underlying apoe4 structural biology 50%

related🔬What are the mechanisms underlying what are the mechanisms b50%

related🔬What are the mechanisms underlying mechanistic role of apoe 50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

related🔬What are the mechanisms underlying apoe4 structural biology 50%

related🔬What are the mechanisms underlying what are the mechanisms b50%

related🔬What are the mechanisms underlying mechanistic role of apoe 50%

related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

related🧪Piezoelectric Nanochannel BBB Disruption50%

related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism50%

related🧪Magnetosonic-Triggered Transferrin Receptor Clustering50%

see_also📖al002-trem2-agonist-alzheimers50%

see_also📖CORT108297 Phase 2 (NCT04601038) - Stress Attenuation in AD50%

see_also📖DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulat50%

see_also📖Donanemab TRAILBLAZER-ALZ 2 Trial50%

see_also📖MK-1167 Phase 2 AD Trial (MK-1167-008)50%

see_also📖A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month50%

see_also📖A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, M50%

see_also📖A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial50%

see_also📖Trontinemab (RO7126209) Phase 3 Trial — TRONTIER 2 (NCT0717050%

see_also📖UB-311 Alzheimer's Vaccination Trial50%

related🧫s:** - Biochemical binding assays measuring PROTAC selectivi45%

related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti45%

related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera45%

related🧫ApoE4 Function in Alzheimer's Disease45%

related🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise45%

related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau45%

related🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#45%

related🧫Blood-Based Biomarker Panel for Early AD Detection45%

related🧫CRISPR Gene Correction Approaches for CBS/PSP45%

related🧫Sex Differences in Alzheimer's Disease — mechanisms and45%

see_also📖Cannabidiol for Alzheimer's Disease Prevention (NCT058245%

see_also📖EI-1071 Immunomodulator for Alzheimer's Disease (NCT06745%

see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI45%

see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St45%

see_also📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451645%

see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime45%

mentions🔬Analyze circuit-level changes in neurodegeneration using All40%